HCV Eradication With DAAs Reduces Variceal Bleeding Risk HCV Eradication With DAAs Reduces Variceal Bleeding Risk
This study found that DAA-induced SVR in patients with hepatitis C is associated with a reduced risk of variceal bleeding, among both patients with and without established cirrhosis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 19, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

HCV Eradication With DAA Improves Insulin Resistance HCV Eradication With DAA Improves Insulin Resistance
This study aimed to assess whether SVR after direct-acting antivirals could improve the degree of insulin resistance in HCV-infected patients, including those with cirrhosis.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Nonalcoholic Liver Disease'an Epidemic of the 21st Century'Nonalcoholic Liver Disease'an Epidemic of the 21st Century '
Can trigger a cascade of reactions, leading to liver cirrhosis, hepatocellular carcinoma, and liver failure, explains an expert.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 5, 2020 Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news

AbbVie Receives Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis
If approved by the European Commission (EC), MAVIRET will be the only pan-genotypic (GT1-6) 8-week treatment option for treatment-naïve, chronic hepatitis C (HCV) patients, without cirrhosis or with compensated cirrhosis Final European Commission ... Biopharmaceuticals, Regulatory AbbVie, MAVIRET, glecaprevir, pibrentasvir, hepatitis C (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2020 Category: Pharmaceuticals Source Type: news

Roche submits supplemental Biologics License Application to the FDA for Tecentriq in combination with Avastin for the most common form of liver cancer
      ·Application is being reviewed under FDA ’s Real-Time Oncology Review pilot programmeBasel, 27 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Food and Drug Administration (FDA) for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab), for the treatment of people with unresectab le hepatocellular carcinoma (HCC) who have not received prior systemic therapy. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, wh...
Source: Roche Investor Update - January 27, 2020 Category: Pharmaceuticals Source Type: news

Guidance Issued for Hepatic, Mesenteric Circulation Disorders
Recommendations address bleeding and thrombotic risk in cirrhosis; portal, mesenteric vein thrombosis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 13, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Pathology, Pharmacy, Radiology, Journal, Source Type: news

Coblopasvir and Sofosbuvir in Patients With HCV Infection Coblopasvir and Sofosbuvir in Patients With HCV Infection
This study investigated the safety and efficacy of coblopasvir plus sofosbuvir in a broad range of HCV infections, including those with compensated cirrhosis.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Clopidogrel Appropriate for PCI in Liver Transplant Candidates Clopidogrel Appropriate for PCI in Liver Transplant Candidates
In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 8, 2020 Category: Surgery Tags: Cardiology News Source Type: news

Walk your way to better health: Regular physical activity linked to lower risk of cirrhosis-related death
(Natural News) It cannot be stressed enough that physical activity, such as walking and working out, is vital for improving overall health. Now, a recent study suggests that physical activity can significantly benefit people suffering from liver disease. The study, presented at Digestive Disease Week 2019, found that physical activity was linked to a significant reduction in the... (Source: NaturalNews.com)
Source: NaturalNews.com - December 12, 2019 Category: Consumer Health News Source Type: news

Researchers create accurate model of organ scarring using stem cells in a lab
Every organ in the body is capable, to some extent, of repairing itself after an injury. As part of this process, scar tissue forms and then recedes to make room for normal tissue when healing is complete.However, when healing is disrupted — whether by chronic injury or disease — the cells that make up scar tissue can go rogue, continuously dividing and spreading until the scar eventually strangles the organ it was intended to help heal, which can lead to organ failure.That progressive, out-of-control scarring is called fibrosis, and it can occur in any organ in the body. Fibrosis plays a major role in many dis...
Source: UCLA Newsroom: Health Sciences - December 11, 2019 Category: Universities & Medical Training Source Type: news

Inappropriate Prescriptions Common in Cirrhosis Inappropriate Prescriptions Common in Cirrhosis
Patients with decompensated cirrhosis are not always taking recommended medications, a review of prescription records shows, and some drugs could cause harm.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 21, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Ammonia levels do not aid management of hepatic encephalopathy in cirrhotic patients
(Medical University of South Carolina) Hepatic encephalopathy (HE) is a reversible complication of liver cirrhosis thought to be caused by ammonia and is typically treated with lactulose. Researchers at the Medical University of South Carolina conducted a cohort study that examined the correlation of ammonia levels with lactulose treatment. They found no correlation between ammonia level and dose of lactulose given. They concluded that ammonia levels are not helpful for clinicians in the management of HE in cirrhotic patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 19, 2019 Category: International Medicine & Public Health Source Type: news

Mortality Rate for Chronic Liver Disease Underestimated Mortality Rate for Chronic Liver Disease Underestimated
If cirrhosis-related deaths were included in the CDC definition of chronic liver disease, mortality rates reported might be more accurate, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Cirrhosis Patients Skimp on Cancer Screening Because of Cost Cirrhosis Patients Skimp on Cancer Screening Because of Cost
Patients at high risk for liver cancer report that expense is often an obstacle to preventive screening and care, putting their lives at risk, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Patients With Cirrhosis Have Considerable Financial Burden
FRIDAY, Nov. 8, 2019 -- The considerable financial burden of cirrhosis medical care is associated with lower surveillance for hepatocellular carcinoma (HCC), according to a study presented at The Liver Meeting, the annual meeting of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 8, 2019 Category: Pharmaceuticals Source Type: news

Characteristics, Trends of HCC in Patients Without Cirrhosis Characteristics, Trends of HCC in Patients Without Cirrhosis
This study aimed to describe the frequency and characteristics of non-cirrhotic hepatocellular carcinoma. What contribution does NAFLD make to the burden of non-cirrhotic HCC?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 30, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Mayo scientists reverse fibrosis in preclinical studies
ROCHESTER, Minn. -- In cell and mouse models, Mayo Clinic researchers and collaborators have identified a way to slow and reverse the process of uncontrolled internal scarring, called fibrosis. This disease process has few effective therapies, no cure and can be fatal when it occurs in organs such as the liver (cirrhosis) or lungs (pulmonary [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - October 30, 2019 Category: Hospital Management Source Type: news

iRhom2 inhibits bile duct obstruction-induced liver fibrosis
Chronic liver disease can induce prolonged activation of hepatic stellate cells, which may result in liver fibrosis. Inactive rhomboid protein 2 (iRhom2) is required for the maturation of A disintegrin and metalloprotease 17 (ADAM17, also called TACE), which is responsible for the cleavage of membrane-bound tumor necrosis factor–α (TNF-α) and its receptors (TNFRs). Here, using the murine bile duct ligation (BDL) model, we showed that the abundance of iRhom2 and activation of ADAM17 increased during liver fibrosis. Consistent with this, concentrations of ADAM17 substrates were increased in plasma samples f...
Source: Signal Transduction Knowledge Environment - October 29, 2019 Category: Science Authors: Sundaram, B., Behnke, K., Belancic, A., Al-Salihi, M. A., Thabet, Y., Polz, R., Pellegrino, R., Zhuang, Y., Shinde, P. V., Xu, H. C., Vasilevska, J., Longerich, T., Herebian, D., Mayatepek, E., Bock, H. H., May, P., Kordes, C., Aghaeepour, N., Mak, T. W., Tags: STKE Research Articles Source Type: news

Nonalcoholic Steatohepatitis with Compensated Cirrhosis: Developing Drugs for Treatment Guidance for Industry
Guidance for Industry (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 25, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network metaanalysis
This review (12 trials, n=1278; 13 antibiotics) found short ‐term mortality after spontaneous bacterial peritonitis (SBP) is approx. 25%. However, authors report significant uncertainty about which antibiotic therapy is better in people with SBP. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 25, 2019 Category: Consumer Health News Source Type: news

Safety of Non-selective b-Blockers in Decompensated Cirrhosis Safety of Non-selective b-Blockers in Decompensated Cirrhosis
Treatment with non-selective beta blockers in patients with decompensated cirrhosis and ascites remains controversial. What factors might contribute to adverse events?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Mavyret Approved as 8-Week Treatment for Hep C, Compensated Cirrhosis
Title: Mavyret Approved as 8-Week Treatment for Hep C, Compensated CirrhosisCategory: Health NewsCreated: 10/1/2019 12:00:00 AMLast Editorial Review: 10/1/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 1, 2019 Category: Nutrition Source Type: news

Mavyret Approved as 8-Week Treatment for Hep C, Compensated Cirrhosis
MONDAY, Sept. 30, 2019 -- Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through 6 and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 30, 2019 Category: General Medicine Source Type: news

FDA Approves Mavyret (glecaprevir/pibrentasvir) Treatment Duration of Eight Weeks for Treatment-Na ïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes
NORTH CHICAGO, Ill., Sept. 26, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Mavyret (glecaprevir/pibrentasvir)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 27, 2019 Category: Drugs & Pharmacology Source Type: news

FDA Further Expands Approval of HCV Combo Drug Mavyret FDA Further Expands Approval of HCV Combo Drug Mavyret
Mavyret is the first 8-week treatment approved for all treatment-naive adult and certain pediatric patients with any hepatitis C virus genotype, both without cirrhosis and with compensated cirrhosis.FDA Approvals (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 27, 2019 Category: Transplant Surgery Tags: Gastroenterology News Alert Source Type: news

Sepsis in patients with cirrhosis awaiting liver transplantation: new trends and management
Bacterial infections are more frequent and severe in patients with advanced liver disease and, therefore, in liver transplant candidates. The increased risk of infection in these patients parallels the severity of the immune dysfunction associated with cirrhosis, featured by systemic inflammation and progressive immunodeficiency. Other factors contribute to this risk, such as genetic polymorphisms, proton-pump inhibitor overuse, the numerous invasive procedures and hospitalizations these patients go through, or the immunosuppressive effects of malnutrition or alcohol abuse. Bacterial infections have a great impact on disea...
Source: Current Awareness Service for Health (CASH) - September 19, 2019 Category: Consumer Health News Source Type: news

Sepsis-related Organ Failure Assessment Score is a strong predictor of survival in acute-on-chronic liver failure
The objective of this study was to identify variables associated with mortality. The mortality was high in these severely ill patients, even when they received optimum supportive therapy in the ICU. The finding that the SOFA score and age best predicted mortality shows that the increased mortality was caused mainly by insufficiency of organs other than the liver. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 4, 2019 Category: Consumer Health News Source Type: news

HCC and DAA Treatment in Decompensated Cirrhosis HCC and DAA Treatment in Decompensated Cirrhosis
This review explores controversies surrounding the potential impact of DAA therapy on the incidence and prognosis of hepatocellular carcinoma in patients with advanced liver disease.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 28, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

The effect of cirrhosis on trauma outcomes: a systematic review and meta-analysis - Serrano E, Liu P, Nwabuo AI, Langness S, Juillard C.
BACKGROUND: The negative effect of cirrhosis on mortality following traumatic injury has been quantified in multiple observational studies. However, to our knowledge, the information contained in these studies has never been synthesized. The aims of this s... (Source: SafetyLit)
Source: SafetyLit - August 10, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

SWE identifies malignant breast microcalcifications
Ultrasound with a shear-wave elastography (SWE) technique can distinguish benign...Read more on AuntMinnie.comRelated Reading: SWE improves plantar fasciitis diagnosis Shear-wave elastography useful for assessing rectal tumor depth Shear-wave elastography helps diagnose Graves' disease SWE helps clinicians evaluate Achilles tendon health 2D shear-wave elastography diagnoses cirrhosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 29, 2019 Category: Radiology Source Type: news

HCC in Patients With NAFLD Without Cirrhosis HCC in Patients With NAFLD Without Cirrhosis
This study compared the clinical characteristics of patients with non-cirrhotic NAFLD-HCC to those with cirrhosis. Do outcomes differ between the two groups?Liver International (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 12, 2019 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news

The Albumin Effect in Cirrhosis Becomes Clearer The Albumin Effect in Cirrhosis Becomes Clearer
Dr David Johnson on how a new study sheds light on the benefits of IV albumin and why it may soon be standard of care in this indication.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 10, 2019 Category: Gastroenterology Tags: Gastroenterology Viewpoint Source Type: news

Outcomes in HBV-related Acute on Chronic Liver Failure Outcomes in HBV-related Acute on Chronic Liver Failure
This study compared the 5-year survival rate and incidence rate of hepatocellular carcinoma between patients with HBV-related acute on chronic liver failure and HBV cirrhosis.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 10, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

SWE improves plantar fasciitis diagnosis
Shear-wave elastography (SWE) boosts diagnostic accuracy in patients with plantar...Read more on AuntMinnie.comRelated Reading: Shear-wave elastography useful for assessing rectal tumor depth Shear-wave elastography helps diagnose Graves' disease SWE helps clinicians evaluate Achilles tendon health 2D shear-wave elastography diagnoses cirrhosis Ultrasound options abound for diagnosing liver disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 3, 2019 Category: Radiology Source Type: news

Ultrasound useful for evaluating liver steatosis
Ultrasound is a reliable alternative to MRI for assessing liver steatosis in...Read more on AuntMinnie.comRelated Reading: Ultrasound identifies alcohol-induced liver disease Steatosis complicates MR elastography for liver fibrosis US elastography for liver evaluation: Worth the cost? HCC screening boosts survival rate in cirrhosis patients Practice of Ultrasound: Part 13 -- Liver fat and fibrosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 31, 2019 Category: Radiology Source Type: news

Cirrhosis, cancer risks higher with fatty liver - especially in diabetics
(Reuters Health) - Fatty liver disease that's not related to alcohol use is linked with an increased risk of cirrhosis and liver cancer, especially in people with diabetes, according to a large study from Europe. (Source: Reuters: Health)
Source: Reuters: Health - May 27, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Adverse Liver Outcomes Up With Diagnosis of NAFLD/NASH
WEDNESDAY, May 22, 2019 -- The risks for cirrhosis and hepatocellular carcinoma (HCC) are increased for patients with a recorded diagnosis of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 22, 2019 Category: Pharmaceuticals Source Type: news

Medical News Today: Cirrhosis and liver cancer risk higher in people with type 2 diabetes
A large European study now suggests that many diagnoses of cirrhosis and liver cancer come too late, and that diabetes might be an independent risk factor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 21, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Walking and strength training may decrease the risk of dying from liver disease
(Digestive Disease Week) Physical activity, including walking and muscle-strengthening activities, were associated with significantly reduced risk of cirrhosis-related death, according to research presented at Digestive Disease Week ® (DDW) 2019. Chronic liver disease is increasing, partly due to the obesity epidemic, and currently there are no guidelines for the optimal type of exercise for the prevention of cirrhosis-related mortality. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2019 Category: International Medicine & Public Health Source Type: news

Diabetes patients at higher risk of deadly liver disease, finds study of 18 million people
(Queen Mary University of London) Many patients with potentially deadly liver cirrhosis and liver cancer are being diagnosed at late advanced stages of disease, according to a study led by Queen Mary University of London and the University of Glasgow. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2019 Category: International Medicine & Public Health Source Type: news

Shear-wave elastography useful for assessing rectal tumor depth
Shear-wave elastography (SWE) is a useful way to evaluate the depth of invasion...Read more on AuntMinnie.comRelated Reading: Shear-wave elastography helps diagnose Graves' disease SWE helps clinicians evaluate Achilles tendon health 2D shear-wave elastography diagnoses cirrhosis Ultrasound options abound for diagnosing liver disease Elastography works for diagnosing soft-tissue lesions (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 17, 2019 Category: Radiology Source Type: news

Effect of a multistrain probiotic on cognitive function and risk of falls in patients with cirrhosis: a randomized trial - Rom án E, Nieto JC, Gely C, Vidal S, Pozuelo M, Poca M, Juárez C, Guarner C, Manichanh C, Soriano G.
Probiotics can modulate gut microbiota, intestinal permeability, and immune response and could therefore improve cognitive dysfunction and help avoid potential consequences, such as falls, in patients with cirrhosis. The aim of this study was to evaluate t... (Source: SafetyLit)
Source: SafetyLit - May 10, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Shear-wave elastography helps diagnose Graves' disease
Shear-wave elastography (SWE) is an effective additional tool to complement...Read more on AuntMinnie.comRelated Reading: Elastography can help characterize breast tumors SWE helps clinicians evaluate Achilles tendon health 2D shear-wave elastography diagnoses cirrhosis Ultrasound options abound for diagnosing liver disease Elastography works for diagnosing soft-tissue lesions (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 24, 2019 Category: Radiology Source Type: news

New class of medicines shows promise
'Gene silencing' spares patients the crippling pain of intermittent porphyria Related items fromOnMedica Higher cancer risk from chronic diseases Hepatocellular carcinoma risk, cirrhosis and hepatitis C Kidney disease hits 850 million people Commonest genetic mutation causes much morbidity Prevention screening for one third of population (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 15, 2019 Category: UK Health Source Type: news

The Big Number: 17.6 million Americans suffer from alcoholism
Beyond affecting everyday life functioning, alcohol abuse increases risk of cancer, liver cirrhosis, heart problems and stroke. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 6, 2019 Category: Consumer Health News Authors: Linda Searing Source Type: news

Fecal Microbiome Signature Detects Cirrhosis in Nonalcoholic Fatty-Liver Disease Fecal Microbiome Signature Detects Cirrhosis in Nonalcoholic Fatty-Liver Disease
A fecal microbiome signature accurately detects cirrhosis in patients with nonalcoholic fatty-liver disease (NAFLD), researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 5, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Glecaprevir/Pibrentasvir in Chronic HCV Genotype 3 Infection Glecaprevir/Pibrentasvir in Chronic HCV Genotype 3 Infection
Is glecaprevir/pibrentasvir effective in patients with chronic HCV genotype 3 infection and compensated cirrhosis?Journal of Viral Hepatitis (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 3, 2019 Category: Intensive Care Tags: Gastroenterology Journal Article Source Type: news

Exosomes from Blood Carry RNA Signatures of Liver Cancer
A small study finds that the tiny extracellular vesicles from patients with hepatocellular carcinoma have RNA content distinct from patients with cirrhosis only. (Source: The Scientist)
Source: The Scientist - April 2, 2019 Category: Science Tags: News & Opinion Source Type: news

Researcher finds dangerous levels of metals in liquor sold in Uganda
UCLA Extension ’s Ochan Otim is a chemist who specializes in developing methods for quantifying and assessing the health risk associated with organic and metal contaminants in the environment. For the last few years, Otim, who grew up in Uganda, has been driven to use his expertise to try to help solve a dangero us mystery in his country of birth.Why were so many people having health problems and even dying because of alcohol consumption?The two-decade civil war in Uganda beginning in the late 1980s ravaged the country with violence, abductions, concentration camps and  starvation. The inhumane conditions and ab...
Source: UCLA Newsroom: Health Sciences - April 2, 2019 Category: Universities & Medical Training Source Type: news

What Does the Liver Do?
Discussion The liver is one of the largest organs in the body, weighing just over 3 pounds in an adult. It is found in the upper right abdomen, under the right dome of the diaphragm. Grossly, it has asymmetric lobes with the right being larger than the left. The lobes are separated by a fibrous connective tissue band that also anchors the liver in the abdominal cavity. The gallbladder is located on the inferior surface of the liver and stores bile, which is then released into the duodenum. Microscopically, the liver cells are arranged in lobules with canals carrying blood vessels and bile ducts. At any moment about 10-13% ...
Source: PediatricEducation.org - April 1, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news